Poly ε-Caprolactone Scaffolds: Advancements in Bone Regeneration and Grafting

In orthopedics and oncology, benign and malignant bone lesions pose significant clinical challenges. Malignant tumors, like osteosarcomas and multiple myeloma, pose substantial health dangers and can spread common and mostly non-life-threatening benign lesions, including non-sizing fibromas and unicameral bone cysts. Treatment plans for bone lesions may involve radiation, chemotherapy, and surgical excision, depending on their type. Combining stem cell research, bioactive materials, and advanced scaffold design, cutting-edge tissue engineering innovations provide novel approaches to bone repair. Poly ε-caprolactone (PCL) scaffolds' biocompatible and biodegradable properties have made them an important instrument in the area since they encourage the osteogenic growth of mesenchymal stem cells. PCL scaffolds encourage the adhesion, development, and specialization of cells into osteoblasts by establishing an optimal microenvironment that replicates the conditions of actual bone tissue. Recent research indicates that PCL scaffolds are efficient in inducing the regeneration of bone tissue when subjected to osteogenic factors and other bioactive additives. This review underlines the need for PCL scaffolds to enhance the mechanism of bone healing and regeneration, thereby confirming their ability to transform the method of treating bone illnesses and accidents. Using ongoing research and pragmatic use in clinical environments, PCL scaffolds can provide unique and effective strategies to improve patient outcomes in allograft treatment.